For information only. Not investment advice, a recommendation, an offer or a solicitation, and without regard to any recipient’s objectives or circumstances. Figures come from third-party sources believed reliable but not guaranteed, and market data may be delayed. Past performance is not a reliable indicator of future results. | ||||||||||||||||||||||||||||||||||||||||||||||||||
![]() Morgan StanleyMS US · Financials · USD Current price$166.68as of Nov 20, 2026 Summary
Analyst consensusStrong Buy 2Buy 9Hold 14Sell 122 analysts 3-year price (USD)Factor profileMulti-factor score 31 / 100 Market data
Business descriptionMorgan Stanley (MS) is a global financial services firm providing investment banking, securities trading, and wealth management. The firm operates through Institutional Securities, Global Wealth Management, and Investment Management segments. 75% of 2025 revenue from the Americas, with accelerating international growth (Asia +23% Y/Y, Europe +16% Y/Y). Competitive moat
Recent developments
Investment risks / red flags
Financials
Classification
|
Last updated: Oct 18, 2026
Current price: $166.68 · Nov 20, 2026· USD
CFRA Ratingbuy12-Mo Target: $235.00
TBI Multi Score31
Theme Exposure
Loading graph…
Factor Profile (Spider Chart)
TBI ModelPrice Chart (TradingView)
Symbol: MSBusiness description
Morgan Stanley (MS) is a global financial services firm providing investment banking, securities trading, and wealth management. The firm operates through Institutional Securities, Global Wealth Management, and Investment Management segments. 75% of 2025 revenue from the Americas, with accelerating international growth (Asia +23% Y/Y, Europe +16% Y/Y).
Competitive moat
- Wealth Management Engine: World-class asset gathering platform with client conversion funnel (Workplace → E*TRADE → full-service advisory). Only 18% lending penetration represents massive growth runway. ~$1T of private equity investments awaiting monetization by financial sponsors.
- Investment Banking Leadership: Lead underwriter for SpaceX (largest IPO in history at $86.3B), leading candidate for Anthropic and OpenAI IPOs. This confirms fee concentration at the top of the market for transformational AI/tech deals.
- Global Trading Dominance: Strong execution across equities and fixed income. Very active trading markets benefiting from market volatility and high investor participation.
- AI Integration: Active deployment of advanced AI models (Claude Mythos) for operational automation, co-piloting tools for financial advisers, and improved efficiency ratios.
Recent developments
- CFRA Strong Buy (5-STARS): MS called "primary beneficiary of a risk-on market environment" with potential for significant fee jumps from mega-cap IPOs (SpaceX, Anthropic, OpenAI). Target $235.
- CFRA downgrade to Buy (per 10/08/2026 CSV): Rating moved to Buy/4-STARS from Strong Buy/5-STARS; date and rationale of the specific downgrade not yet ingested from a dedicated CFRA note.
- IPO Supercycle Exposure: Global IPO proceeds tripled Y/Y to $170B in 1H 2026. SpaceX alone generated $86.3B. OpenAI and Anthropic at potential $1T+ valuations. MS is positioned as co-lead or lead underwriter on all three.
- Investment Banking Revenue Surge: ECM underwriting fees +60% Y/Y globally. M&A advisory +18%. Record pipeline building for IPO activity in 2H 2026.
- Wealth Management Opportunity: Client acquisition funnel from Workplace/E*TRADE to advisory is a "massive and accelerating opportunity." Lending penetration only 18% — significant room to grow.
- Capital Strength: CET1 ratio 15.1%. $1.75B share repurchases in Q1 2026. Book value per share $66.18 (+9.6% Y/Y). Management committed to shareholder returns.
- Private Credit Market: Management acknowledged private credit challenges as an "adolescent moment" — managing market concerns while projecting confidence in long-term viability.
Investment risks / red flags
- ⚠️ Market Concentration: Heavy reliance on capital markets activity. A "black swan" event or geopolitical escalation (Iran-U.S. conflict) could freeze IPO/M&A activity.
- ⚠️ Rate Sensitivity: Fed rate hikes could compress valuations on pre-profitability IPO pipeline companies and slow the deal cycle.
- ⚠️ SpaceX Aftermarket Risk: SpaceX down ~20% from peak; lock-up expiration creates supply overhang. Sluggish aftermarket could delay OpenAI/Anthropic timelines.
- ⚠️ H-Score vs CFRA Divergence ⚠️: TBI multi factor score of 31 (per 11/16/2026 CSV) contrasts with CFRA Buy (4-STARS, downgraded from Strong Buy). This divergence reflects a structural catalyst thesis where IPO supercycle revenues are not captured by quantitative momentum/value models.
Market Data
Source: mkts.io · Nov 20, 2026, 20:01 UTC
Key Metrics
P/E (TTM)13.21
P/E (Fwd)12.22
Dividend2.63%
Beta1.22
52W High$232.25
52W Low$152.80
Analyst Consensus
9
14
Strong Buy2Buy9Hold14Sell122 analysts
Consensus Target$211.50
+26.9% upside
Calendar Events
Next EarningsJan 14, 2027
Ex-DividendOct 30, 2026
Dividend DateNov 13, 2026
Financials
Revenue$79.79B
Rev Growth10.80%
Earnings Growth8.20%
Gross Margin87.31%
Op Margin40.20%
Profit Margin25.63%
ROA1.35%
ROE18.04%
Rev/Share$51.26
Total Cash$767.41B
Total Debt$579.49B
D/E Ratio489.76
Op Cash Flow-$58.28B
Current Ratio2.12
Forward Estimates
| Period | EPS Est | Rev Est |
|---|---|---|
| 0q | 2.94 | $20.37B |
| +1q | 3.57 | $21.92B |
| 0y | 12.91 | $82.49B |
| +1y | 13.66 | $86.64B |
Earnings
Quarterly EPS
4Q2025
Est: 2.452.68Beat
1Q2026
Est: 3.023.43Beat
2Q2026
Est: 2.933.46Beat
3Q2026
Est: 2.923.03Beat
Annual
2022
Rev $53.67BEarn $10.54B
2023
Rev $54.14BEarn $8.53B
2024
Rev $61.76BEarn $12.80B
2025
Rev $70.64BEarn $16.25B
Rating Changes
| Date | Firm | Action | To |
|---|---|---|---|
| Nov 2, 2026 | UBS | main | Buy |
| Oct 19, 2026 | BMO Capital | main | Outperform |
| Oct 16, 2026 | JP Morgan | main | Neutral |
| Oct 15, 2026 | Citigroup | main | Neutral |
| Oct 15, 2026 | RBC Capital | main | Sector Perform |
| Oct 15, 2026 | TD Cowen | main | Hold |
